Boehringer Ingelheim BioXcellence is the contract biopharmaceutical manufacturing arm of Boehringer Ingelheim, one of the world's largest pharmaceutical companies. BioXcellence offers end-to-end biologics CDMO services including mammalian cell culture, microbial fermentation, viral vector production, and aseptic fill/finish with extensive FDA, EMA, and PMDA regulatory approvals across multiple global facilities.
Mammalian cell culture, microbial fermentation, viral vectors, monoclonal antibodies, aseptic fill/finish, cell & gene therapy
4 sites worldwide
Involvement in 197 clinical trials
No reviews available yet.
No documents available.